Life sciences industry calls for Brexit transition period

The EU and UK must make progress in Brexit negotiations “as soon as possible”, according to the associations that represent the European and British life sciences industry.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

After Brexit: new directions for clinical trials

10 October 2017 If the UK government changes the rules for clinical trials after Brexit, the regimes in the UK and the EU will diverge and possibly make trials more complex and costly, as Rachel Bradley of Penningtons Manches reports.

Big Pharma

Big pharma companies react to ‘Brexit’

28 June 2016 Following the result of the UK’s referendum on membership of the EU, pharmaceutical companies have yet to find out how this will affect their businesses.

More on this story

Big Pharma

Big pharma companies react to ‘Brexit’

28 June 2016 Following the result of the UK’s referendum on membership of the EU, pharmaceutical companies have yet to find out how this will affect their businesses.

Big Pharma

After Brexit: new directions for clinical trials

More on this story

Big Pharma

Big pharma companies react to ‘Brexit’

28 June 2016 Following the result of the UK’s referendum on membership of the EU, pharmaceutical companies have yet to find out how this will affect their businesses.

Big Pharma

After Brexit: new directions for clinical trials